Remus Pharmaceuticals Ltd

Registered Office: 1101 to 1103 South Tower One42,B/H Ashok Vatika Amblibopal Rd, Ahmedabad - 380054, Gujarat, India. Phone : 91-079-29999857   Fax: Email : cs@remuspharma.com Website :www.remuspharma.com

Initial public issue of 388000 equity shares of face value of Rs. 10/- each of Remus Pharmaceuticals Limited ("RPL" or the "Company" or the "Issuer") for cash at a price of Rs. 1229/- per equity share including a share premium of Rs. 1219/- per equity share (the "Issue Price") aggregating to Rs. 47.69 crores ("The Issue"), of which 19500 equity shares of face value of Rs. 10/- each for cash at a price of Rs. 1229/- per equity share including a share premium of Rs. 1219/- per equity share aggregating to Rs. 2.40 crores will be reserved for subscription by market maker to the issue (the "Market Maker Reservation Portion"). The issue less the market maker reservation portion i.e. net issue of 368500 equity shares of face value of Rs. 10/- each at a price of Rs. 1229/- per equity share including a share premium of Rs. 1219/- per equity share aggregating to Rs. 45.29 crores is herein after referred to as the "Net Issue". The issue and the net issue will constitute 26.34% and 25.02%, respectively, of the post issue paid up equity share capital of the company. The face value of the equity shares is Rs. 10/- each. Issue Opens On Closes On 17-May-23 19-May-23 Money Payable On Application Allotment 1229.00 0.00 Minimum Application for shares in Nos : 100 Further Multiples of : 100 RsCr Lead Managers to the Issue Project Cost (Rs.Cr) 46.69 Beeline Capital Advisors Pvt Ltd Project Financed through Current Offer (Rs.Cr) 47.69   Post Issue Equity Share Capital (Rs.Cr) 1.47 Issue Price (Rs) 1229.00

Projects

To Meet Working Capital Requirements Funding investments for acquisitions & general corporate purposes

Promoted By

Arpit Deepakkumar Shah

Roma Vinodbhai Shah

Swapnil Jatinbhai Shah

Listing At

NSE - SME

Registrar to the Issue

No Data Available